Vascepa to Accelerate Lipoprotein Uptake and Elimination

Summary

This study is a Phase 1 pilot/feasibility mechanistic experiment to help clarify the mechanism of action of an EPA-rich fish oil preparation, icosapent ethyl, on lipid changes in statin-treated patients with residual triglyceridemia.

Timeline

Start

2016-01-11

Primary completion

2018-08

Completion

2021-06

Drugs

Indications